By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

SYGNIS Pharma AG 

Im Neuenheimer Feld 515

Heidelberg    69120  Germany
Phone: 49 6221 454 6 Fax: 49 6221 454 700


SEARCH JOBS


Industry
Pharmaceutical






Company News
SYGNIS Reports Results For The First Quarter 2015 5/13/2015 11:58:01 AM
SYGNIS Signs Non-Exclusive Distribution Agreement With Cambridge Bioscience Ltd For UK And Ireland 5/4/2015 7:13:38 AM
SYGNIS Reports Financial Results For Fiscal Year 2014 4/29/2015 8:39:11 AM
SYGNIS To Host Live Webinar On Its Revolutionary TrueprimeTechnology For Primer-Free Whole Genome Amplification (WGA) 3/11/2015 8:55:55 AM
SYGNIS Pharma AG Presents Its First Own Product Line Based On PrimPol Technology: TruePrime 11/20/2014 11:15:32 AM
SYGNIS Pharma AG Release: GBC Research Reiterates “BUY” Recommendation For SYGNIS Shares With Price Target Of €4.05 11/19/2014 1:33:08 PM
SYGNIS Pharma AG’ New TthPrimPol Polymerase Took Centre Stage At Zing DNA Polymerases Conference 2014 9/22/2014 12:37:25 PM
SYGNIS Pharma AG Reports Half-Year Results For The Period Ended June 30, 2014 8/14/2014 2:08:05 PM
GBC Research Reiterates "BUY" Recommendation On SYGNIS Pharma AG With A Price Target Of EUR6.00 4/16/2014 10:01:01 AM
First SYGNIS Pharma AG QualiPhi® -Based Products Launched By QIAGEN Inc. (QGEN) 2/12/2014 1:36:29 PM
123456
//-->